Chargement en cours...
Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma
Objective. To quantify the benefits in survival and quality of life in patients receiving bevacizumab (BEV) for recurrent glioblastoma (GBM). Methods. This is a retrospective study of 40 adult patients with recurrent GBM treated between 2005 and 2009 at a single institution. All patients had initial...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263615/ https://ncbi.nlm.nih.gov/pubmed/22312554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/602812 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|